Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
ABOUT THIS PAGE
16
PharmaCompass offers a list of Sitafloxacin Hydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sitafloxacin Hydrate manufacturer or Sitafloxacin Hydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sitafloxacin Hydrate manufacturer or Sitafloxacin Hydrate supplier.
A sitafloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of sitafloxacin, including repackagers and relabelers. The FDA regulates sitafloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. sitafloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of sitafloxacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A sitafloxacin supplier is an individual or a company that provides sitafloxacin active pharmaceutical ingredient (API) or sitafloxacin finished formulations upon request. The sitafloxacin suppliers may include sitafloxacin API manufacturers, exporters, distributors and traders.
click here to find a list of sitafloxacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A sitafloxacin DMF (Drug Master File) is a document detailing the whole manufacturing process of sitafloxacin active pharmaceutical ingredient (API) in detail. Different forms of sitafloxacin DMFs exist exist since differing nations have different regulations, such as sitafloxacin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A sitafloxacin DMF submitted to regulatory agencies in the US is known as a USDMF. sitafloxacin USDMF includes data on sitafloxacin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The sitafloxacin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of sitafloxacin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The sitafloxacin Drug Master File in Japan (sitafloxacin JDMF) empowers sitafloxacin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the sitafloxacin JDMF during the approval evaluation for pharmaceutical products. At the time of sitafloxacin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of sitafloxacin suppliers with JDMF on PharmaCompass.
sitafloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of sitafloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right sitafloxacin GMP manufacturer or sitafloxacin GMP API supplier for your needs.
A sitafloxacin CoA (Certificate of Analysis) is a formal document that attests to sitafloxacin's compliance with sitafloxacin specifications and serves as a tool for batch-level quality control.
sitafloxacin CoA mostly includes findings from lab analyses of a specific batch. For each sitafloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
sitafloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (sitafloxacin EP), sitafloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (sitafloxacin USP).
